Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

被引：8
|
作者：
Kreyenberg, H. [1 ]
Eckert, C. [2 ]
Yarkin, Y. [3 ]
Reising, M. [1 ]
Willasch, A. [1 ]
Handgretinger, R. [3 ]
Kremens, B. [4 ]
von Stackelberg, A. [2 ]
Henze, G. [2 ]
Klingebiel, T. [1 ]
Bader, P. [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Paediat Oncol Haematol & Haemostaseol, Childrens Hosp, Frankfurt, Germany
[2] Humboldt Univ, Dept Paediat Oncol Haematol, Charite Hosp, Berlin, Germany
[3] Univ Tubingen, Dept Haematol Oncol, Childrens Univ Hosp, Tubingen, Germany
[4] Univ Essen Gesamthsch, Dept Pediat Haematol Oncol & Endocrinol, Essen, Germany
来源：
LEUKEMIA | 2009年 / 23卷 / 07期
关键词：
CONCERTED ACTION; RELAPSE; PROTOCOLS; CHILDREN; PRIMERS;
D O I：
10.1038/leu.2009.72
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1355 / 1358
页数：5
相关论文
共 50 条
  • [11] Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival
    Logan, Aaron C.
    Vashi, Nikita
    Faham, Malek
    Carlton, Victoria
    Kong, Katherine
    Buno, Ismael
    Zheng, Jianbiao
    Moorhead, Martin
    Klinger, Mark
    Zhang, Bing
    Waqar, Amna
    Zehnder, James L.
    Miklos, David B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1307 - 1313
  • [12] Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR
    VHJ van der Velden
    MJ Willemse
    CE van der Schoot
    K Hählen
    ER van Wering
    JJM van Dongen
    Leukemia, 2002, 16 : 928 - 936
  • [13] Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR
    van der Velden, VHJ
    Willemse, MJ
    van der Schoot, CE
    Hählen, K
    van Wering, ER
    van Dongen, JJM
    LEUKEMIA, 2002, 16 (05) : 928 - 936
  • [14] Capture-Based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes
    Cavagna, Roberta
    Montalvo, Marie L. Guinea
    Tosi, Manuela
    Paris, Michela
    Pavoni, Chiara
    Intermesoli, Tamara
    Bassan, Renato
    Mosca, Andrea
    Rambaldi, Alessandro
    Spinelli, Orietta
    CANCERS, 2020, 12 (06) : 1 - 23
  • [15] Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease
    Ali, Sahra
    Moreau, Alexandre
    Melchiorri, Daniela
    Camarero, Jorge
    Josephson, Filip
    Olimpier, Odoardo
    Bergh, Jonas
    Karres, Dominik
    Tzogani, Kyriaki
    Gisselbrecht, Christian
    Pignatti, Francesco
    ONCOLOGIST, 2020, 25 (04) : E709 - E715
  • [16] The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Zhou, Yi
    Slack, Rebecca
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Rondon, Gabriela
    de Lima, Marcos
    Shpall, Elizabeth
    Popat, Uday
    Ciurea, Stefan
    Alousi, Amin
    Qazilbash, Muzaffar
    Hosing, Chitra
    O'Brien, Susan
    Thomas, Deborah
    Kantarjian, Hagop
    Medeiros, L. Jeffrey
    Champlin, Richard E.
    Kebriaei, Partow
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (04) : 319 - 326
  • [17] The clinical significance of monitoring the expression of the SIL-TAL1 fusion gene in T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    Zhao, X.
    Hong, Y.
    Qin, Y.
    Xu, Y.
    Chang, Y.
    Wang, Y.
    Zhang, X.
    Xu, L.
    Huang, X.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (06) : 613 - 619
  • [18] A systematic review of outcomes after stem cell transplantation in acute lymphoblastic leukemia with or without measurable residual disease
    Shah, Shweta
    Martin, Amber
    Turner, Monica
    Cong, Ze
    Zaman, Faraz
    Stein, Anthony
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1052 - 1062
  • [19] DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia
    Borssen, Magnus
    Haider, Zahra
    Landfors, Mattias
    Noren-Nystrom, Ulrika
    Schmiegelow, Kjeld
    Asberg, Ann E.
    Kanerva, Jukka
    Madsen, Hans O.
    Marquart, Hanne
    Heyman, Mats
    Hultdin, Magnus
    Roos, Goran
    Forestier, Erik
    Degerman, Sofie
    PEDIATRIC BLOOD & CANCER, 2016, 63 (07) : 1185 - 1192
  • [20] Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia
    Modvig, S.
    Madsen, H. O.
    Siitonen, S. M.
    Rosthoj, S.
    Tierens, A.
    Juvonen, V
    Osnes, L. T. N.
    Valerhaugen, H.
    Hultdin, M.
    Thorn, I
    Matuzeviciene, R.
    Stoskus, M.
    Marincevic, M.
    Fogelstrand, L.
    Lilleorg, A.
    Toft, N.
    Jonsson, O. G.
    Pruunsild, K.
    Vaitkeviciene, G.
    Vettenranta, K.
    Lund, B.
    Abrahamsson, J.
    Schmiegelow, K.
    Marquart, H., V
    LEUKEMIA, 2019, 33 (06) : 1324 - 1336
12345